Streptococcal Toxic Shock Syndrome: Diagnostic and Therapeutic Approaches Incorporating Point-of-Care Antigen Testing—Case Series
Abstract
:1. Introduction
2. Results
2.1. Case 1
2.2. Case 2
2.3. Case 3
3. Discussion
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Schmitz, M.; Roux, X.; Huttner, B.; Pugin, J. Streptococcal toxic shock syndrome in the intensive care unit. Ann. Intensive Care 2018, 8, 88. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Sekizuka, T.; Nai, E.; Yoshida, T.; Endo, S.; Hamajima, E.; Akiyama, S.; Ikuta, Y.; Obana, N.; Kawaguchi, T.; Hayashi, K.; et al. Streptococcal toxic shock syndrome caused by the dissemination of an invasive emm3/ST15 strain of Streptococcus pyogenes. BMC Infect. Dis. 2017, 17, 774. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Al-ajmi, J.A.; Hill, P.; O’ Boyle, C.; Garcia, M.L.; Malkawi, M.; George, A.; Saleh, F.; Lukose, B.; Ali, B.A.; Elsheikh, M. Group A Streptococcus Toxic Shock Syndrome: An outbreak report and review of the literature. J. Infect. Public Health 2012, 5, 388–393. [Google Scholar] [CrossRef] [PubMed]
- Proft, T.; Fraser, J.D. Streptococcal superantigens: Biological properties and potential role in disease. In Streptococcus pyogenes: Basic Biology to Clinical Manifestations; Ferretti, J.J., Stevens, D.L., Fischetti, V.A., Eds.; The University Of Oklahoma Health Sciences Center: Oklahoma City, OK, USA, 2016. [Google Scholar]
- Commons, R.J.; Smeesters, P.R.; Proft, T.; Fraser, J.D.; Robins-Browne, R.; Curtis, N. Streptococcal superantigens: Categorization and clinical associations. Trends Mol. Med. 2014, 20, 48–62. [Google Scholar] [CrossRef] [PubMed]
- Proft, T.; Fraser, J.D. Streptococcal superantigens. Chem. Immunol. Allergy 2007, 93, 1–23. [Google Scholar] [CrossRef] [PubMed]
- Walker, M.J.; Barnett, T.C.; McArthur, J.D.; Cole, J.N.; Gillen, C.M.; Henningham, A.; Sriprakash, K.S.; Sanderson-Smith, M.L.; Nizet, V. Disease manifestations and pathogenic mechanisms of group A Streptococcus. Clin. Microbiol. Rev. 2014, 27, 264–301. [Google Scholar] [CrossRef] [PubMed]
- Nelson, G.E.; Pondo, T.; Toews, K.A.; Farley, M.M.; Lindegren, M.L.; Lynfield, R.; Aragon, D.; Zansky, S.M.; Watt, J.P.; Cieslak, P.R.; et al. Epidemiology of invasive group A streptococcal infections in the United States, 2005–2012. Clin. Infect. Dis. 2016, 63, 478–486. [Google Scholar] [PubMed]
- Atchade, E.; De Tymowski, C.; Grall, N.; Tanaka, S.; Montravers, P. Toxic Shock Syndrome: A Literature Review. Antibiotics 2024, 13, 96. [Google Scholar] [CrossRef] [PubMed]
- Stevens, D.L. Streptococcal toxic shock syndrome. Clin. Microbiol. Infect. 2002, 8, 133–136. [Google Scholar] [CrossRef] [PubMed]
- Bryant, A.E.; Stevens, D.L. Streptococcus pyogenes. In Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th ed.; Bennett, J., Dolin, R., Blaser, M., Eds.; Elsevier: Philadelphia, PA, USA, 2015; Volume 2, pp. 2285–2300. [Google Scholar]
- Lamagni, T.L.; Darenberg, J.; Luca-Harari, B.; Siljander, T.; Efstratiou, A.; Henriques-Normark, B.; Vuopio-Varkila, J.; Bouvet, A.; Creti, R.; Ekelund, K.; et al. Epidemiology of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. 2008, 46, 2359–2367. [Google Scholar] [PubMed]
- Vucicevic, Z.; Jajic-Bencic, I.; Kruslin, B.; Degoricija, V. Toxic shock syndrome due to group A streptococcal pharyngitis and bacteremia in adults. J. Microbiol. Immunol. Infect. 2009, 42, 276–279. [Google Scholar] [PubMed]
- Sølvik, U.Ø.; Boija, E.E.; Ekvall, S.; Jabbour, A.; Breivik, A.C.; Nordin, G.; Sandberg, S. Performance and user-friendliness of the rapid antigen detection tests QuickVue Dipstick Strep A test and DIAQUICK Strep A Blue Dipstick for pharyngotonsillitis caused by Streptococcus pyogenes in primary health care. Eur. J. Clin. Microbiol. Infect. Dis. 2021, 40, 549–558. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Dodd, M.; Adolphe, A.; Parada, A.; Brett, M.; Culbreath, K.; Mercier, R.C. Clinical Impact of a Rapid Streptococcal Antigen Test on Antibiotic Use in Adult Patients. Diagn. Microbiol. Infect. Dis. 2018, 91, 339–344. [Google Scholar] [CrossRef] [PubMed]
- Coyle, E.A.; Cha, R.; Rybak, M.J. Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release. Antimicrob. Agents Chemother. 2003, 47, 1752–1755. [Google Scholar] [CrossRef]
- Linnér, A.; Darenberg, J.; Sjölin, J.; Henriques-Normark, B.; Norrby-Teglund, A. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: A comparative observational study. Clin. Infect. Dis. 2014, 59, 851–857. [Google Scholar] [CrossRef]
- Liu, Z.; Jiang, X.; Li, J.; Ji, W.; Zhou, H.; Gong, X.; Miao, B.; Meng, S.; Duan, L.; Shi, Q.; et al. Molecular characteristics and antibiotic resistance mechanisms of clindamycin-resistant Streptococcus agalactiae isolates in China. Front. Microbiol. 2023, 14, 1138039. [Google Scholar] [CrossRef]
- White, B.P.; Siegrist, E.A. Increasing clindamycin resistance in group A streptococcus. Lancet Infect. Dis. 2021, 21, 1208–1209. [Google Scholar] [CrossRef]
- Meletis, G.; Soulopoulos Ketikidis, A.L.; Floropoulou, N.; Tychala, A.; Kagkalou, G.; Vasilaki, O.; Mantzana, P.; Skoura, L.; Protonotariou, E. Antimicrobial resistance rates of Streptococcus pyogenes in a Greek tertiary care hospital: 6-year data and literature review. New Microbiol. 2023, 46, 37–42. [Google Scholar] [PubMed]
- Heil, E.L.; Kaur, H.; Atalla, A.; Basappa, S.; Mathew, M.; Seung, H.; Johnson, J.K.; Schrank, G.M. Comparison of Adjuvant Clindamycin vs. Linezolid for Severe Invasive Group A Streptococcus Skin and Soft Tissue Infections. Open Forum Infect. Dis. 2023, 10, ofad588. [Google Scholar] [CrossRef]
- Campagna, J.D.; Bond, M.C.; Schabelman, E.; Hayes, B.D. The use of cephalosporins in penicillin-allergic patients: A literature review. J. Emerg. Med. 2012, 42, 612–620. [Google Scholar] [CrossRef] [PubMed]
Vital Signs | Patient 1 | Patient 2 | Patient 3 |
---|---|---|---|
Systolic blood pressure (mmHg) | 60 | 88/50 | 85 |
Diastolic blood pressure (mmHg) | 30 | 50 | 52 |
Heart rate (beat/minute) | 160 | 137 | 110 |
Symptoms and signs | |||
Dyspnoea | Present | Present | Present |
Fever | Present | Present | Present |
Rash | Present | Present | Present |
Strawberry tongue | Present | Present | Present |
Laboratory results | |||
C-reactive protein (mg/L) | 321 | 268 | 127 |
Procalcitonin (ng/mL) | 29.4 | 182.7 | 3.3 |
Creatinine (umol/L) | 280 | 82 | 128 |
Interleukin-6 (pg/mL) | 996 | 1036 | 438 |
Lactate (mmol/L) | 3.9 | 2.2 | 2.1 |
Neutrophil count (cells/mL) | 24,700 | 9500 | 22,310 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mihalov, P.; Kovalíková, S.; Laktiš, K.; Bendžala, M.; Sabaka, P. Streptococcal Toxic Shock Syndrome: Diagnostic and Therapeutic Approaches Incorporating Point-of-Care Antigen Testing—Case Series. Clin. Pract. 2025, 15, 70. https://doi.org/10.3390/clinpract15040070
Mihalov P, Kovalíková S, Laktiš K, Bendžala M, Sabaka P. Streptococcal Toxic Shock Syndrome: Diagnostic and Therapeutic Approaches Incorporating Point-of-Care Antigen Testing—Case Series. Clinics and Practice. 2025; 15(4):70. https://doi.org/10.3390/clinpract15040070
Chicago/Turabian StyleMihalov, Peter, Simona Kovalíková, Karol Laktiš, Matej Bendžala, and Peter Sabaka. 2025. "Streptococcal Toxic Shock Syndrome: Diagnostic and Therapeutic Approaches Incorporating Point-of-Care Antigen Testing—Case Series" Clinics and Practice 15, no. 4: 70. https://doi.org/10.3390/clinpract15040070
APA StyleMihalov, P., Kovalíková, S., Laktiš, K., Bendžala, M., & Sabaka, P. (2025). Streptococcal Toxic Shock Syndrome: Diagnostic and Therapeutic Approaches Incorporating Point-of-Care Antigen Testing—Case Series. Clinics and Practice, 15(4), 70. https://doi.org/10.3390/clinpract15040070